As a bispecific ADC, BL-B01D1 binds EGFR (and/or HER3) on tumor cells, is internalized, and releases a topoisomerase I–inhibitor via a cleavable linker, causing DNA single-strand breaks and apoptosis; can also produce bystander killing.